Argos Therapeutics Leadership

Q: Who is the founder of Argos Therapeutics?

Ralph Steinman founded Argos Therapeutics.

Zippia score 3.2

Argos Therapeutics executives

Here are further demographic highlights of the leadership team:

The Argos Therapeutics executive team is 24% female and 76% male.
65% of the management team is White.
11% of Argos Therapeutics management is Hispanic or Latino.
10% of the management team is Black or African American.

Work at Argos Therapeutics?

Share your experience

Rate Argos Therapeutics' leaders' effectiveness in guiding the company.

Name & TitleBio

Ralph Steinman

Founder

Jeffrey D. Abbey

Board Member

Charles A. Nicolette Ph.d

CSO, VP R&D

Charles Nicolette joined Argos Therapeutics in 2003. Dr. Nicolette has extensive experience in the field of cancer immunotherapy and is the inventor on dozens of patent applications and issued patents relating to the development of personalized immunotherapeutics for cancer and infectious diseases. He was formerly the Director of Antigen Discovery at Genzyme Molecular Oncology where he developed SPHERE technology, the subject of one of the largest biotechnology deals ever done in the field of tumor antigen discovery. He is an expert in cellular immunology and brings substantial immunological sophistication to Argos. Dr. Nicolette received his Ph.D. in biochemistry and cellular and developmental biology from the State University of New York at Stony Brook, completing his doctoral dissertation and post-doctoral fellowship at Cold Spring Harbor Laboratory.

Doug C. Plessinger

Vice President

Lori R. Harrelson

Vice President of Finance

Hubert Birner

Board Member

Richard G. Morrison

Board Member

Igor Krol

Board Member

Robert F. Carey

Board Member

Sander van Deventer

Board Member

Do you work at Argos Therapeutics?

Does leadership effectively guide Argos Therapeutics toward its goals?

Argos Therapeutics jobs

Argos Therapeutics founders

Name & TitleBio

Ralph Steinman

Founder

Argos Therapeutics board members

Name & TitleBio

Jeffrey D. Abbey

Board Member

Hubert Birner

Board Member

Richard G. Morrison

Board Member

Igor Krol

Board Member

Robert F. Carey

Board Member

Sander van Deventer

Board Member

Irackly Mtibelishvily

Board Member

Isaac Cheng

Board Member

Argos Therapeutics leadership demographics

Argos Therapeutics gender distribution in management team

The Argos Therapeutics executive team is 24% female and 76% male.
Argos Therapeutics is 51% female and 49% male company-wide.

Male

76%

Company-wide: 49%

Female

24%

Company-wide: 51%

Argos Therapeutics executives by race

Management Team:

The most common ethnicity among Argos Therapeutics executive officers is White.
65% of the management team is White.
11% of Argos Therapeutics's management is Hispanic or Latino.
10% of the management team is Black or African American.

Company-wide:

White is the most common ethnicity company-wide.
58% of employees are White.
16% of employees are Black or African American.
14% of employees are Hispanic or Latino.

Management team
General

100%

80%

60%

40%

20%

Unknown

White

Black or African American

Asian

Hispanic or Latino

Argos Therapeutics jobs nearby

Argos Therapeutics executives FAQs

Who is the founder of Argos Therapeutics?

Related company executives

Working at related companies

Related company jobs

Most in demand jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of Argos Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Argos Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Argos Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Argos Therapeutics. The data presented on this page does not represent the view of Argos Therapeutics and its employees or that of Zippia.

Argos Therapeutics may also be known as or be related to ARGOS THERAPEUTICS INC, Argos Therapeutics, Argos Therapeutics Inc and Argos Therapeutics, Inc.